SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.911
AS - Asia 20.154
EU - Europa 12.626
SA - Sud America 3.059
Continente sconosciuto - Info sul continente non disponibili 736
AF - Africa 465
OC - Oceania 45
AN - Antartide 1
Totale 74.997
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.967
SG - Singapore 7.463
CN - Cina 5.037
FI - Finlandia 2.585
BR - Brasile 2.368
VN - Vietnam 2.340
DE - Germania 2.095
IT - Italia 2.008
UA - Ucraina 1.762
HK - Hong Kong 1.578
TR - Turchia 1.138
GB - Regno Unito 1.059
FR - Francia 628
BD - Bangladesh 570
PL - Polonia 564
SE - Svezia 564
JP - Giappone 532
RU - Federazione Russa 499
CA - Canada 460
IN - India 383
MX - Messico 318
ID - Indonesia 258
AR - Argentina 239
ZA - Sudafrica 170
NL - Olanda 168
ES - Italia 141
IQ - Iraq 141
BE - Belgio 107
EC - Ecuador 107
CO - Colombia 96
PK - Pakistan 94
VE - Venezuela 83
UZ - Uzbekistan 72
MY - Malesia 70
CZ - Repubblica Ceca 64
MA - Marocco 63
AT - Austria 61
LT - Lituania 60
SA - Arabia Saudita 57
CL - Cile 54
KE - Kenya 53
PH - Filippine 53
JM - Giamaica 42
IR - Iran 40
AU - Australia 38
PY - Paraguay 38
PE - Perù 36
CH - Svizzera 35
TN - Tunisia 35
AE - Emirati Arabi Uniti 34
IE - Irlanda 34
JO - Giordania 34
DZ - Algeria 33
NP - Nepal 31
CR - Costa Rica 26
IL - Israele 26
RO - Romania 23
AL - Albania 21
AZ - Azerbaigian 21
KR - Corea 21
PT - Portogallo 21
UY - Uruguay 21
ET - Etiopia 20
EG - Egitto 19
TH - Thailandia 19
TW - Taiwan 19
GR - Grecia 18
BG - Bulgaria 14
KZ - Kazakistan 14
OM - Oman 14
PS - Palestinian Territory 14
DO - Repubblica Dominicana 13
RS - Serbia 13
SN - Senegal 13
TT - Trinidad e Tobago 13
EU - Europa 12
NO - Norvegia 12
BO - Bolivia 11
GT - Guatemala 11
HN - Honduras 11
NG - Nigeria 11
GE - Georgia 10
LB - Libano 10
SV - El Salvador 10
BH - Bahrain 9
KG - Kirghizistan 9
PA - Panama 9
SK - Slovacchia (Repubblica Slovacca) 9
DK - Danimarca 8
HU - Ungheria 8
KW - Kuwait 8
NI - Nicaragua 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
NZ - Nuova Zelanda 7
BA - Bosnia-Erzegovina 6
AF - Afghanistan, Repubblica islamica di 5
AO - Angola 5
BW - Botswana 5
GA - Gabon 5
Totale 74.155
Salva come PNG Salva come JPEG
Città #
Singapore 4.575
Ashburn 3.876
Woodbridge 2.989
Fairfield 2.929
San Jose 2.410
Helsinki 2.130
Houston 1.936
Chandler 1.929
Jacksonville 1.841
Santa Clara 1.684
Hong Kong 1.538
Beijing 1.531
Ann Arbor 1.408
Seattle 1.212
Wilmington 1.116
Dallas 969
Cambridge 963
Ho Chi Minh City 796
New York 714
Izmir 633
Council Bluffs 585
Los Angeles 575
Nanjing 572
Warsaw 544
Hanoi 542
Ferrara 531
Munich 519
Tokyo 505
Princeton 438
Boardman 407
Lauterbourg 370
The Dalles 298
San Diego 279
Milan 263
São Paulo 244
Shanghai 221
Mexico City 208
Orem 191
Nanchang 174
Dearborn 173
Shenyang 171
Jakarta 170
Toronto 169
Buffalo 164
London 163
Bremen 162
Chicago 143
Tianjin 142
Brooklyn 120
Hebei 120
Montreal 115
Rome 114
Hefei 112
Jiaxing 110
Da Nang 106
Frankfurt am Main 105
Falls Church 104
Changsha 101
Denver 100
Turku 99
Brussels 98
Chennai 98
Johannesburg 97
Haiphong 91
Atlanta 86
Phoenix 86
Redwood City 86
Jinan 83
Moscow 76
Falkenstein 75
Norwalk 75
Rio de Janeiro 75
San Mateo 71
Stockholm 71
San Francisco 70
Amsterdam 69
Kunming 68
Manchester 66
Mountain View 65
Guangzhou 64
Tashkent 64
Poplar 60
Nuremberg 59
Belo Horizonte 58
Baghdad 57
Düsseldorf 57
Curitiba 53
Zhengzhou 50
Auburn Hills 49
Boston 49
Biên Hòa 48
Bologna 48
Brno 48
Hải Dương 46
Des Moines 44
Dong Ket 44
Nairobi 44
Philadelphia 43
Addison 42
Brasília 42
Totale 49.983
Salva come PNG Salva come JPEG
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.054
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 429
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 364
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 326
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 312
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 309
AN EXON-SPECIFIC U1 SMALL NUCLEAR RNA (snRNA) STRATEGY TO CORRECT SPLICING MUTATIONS ASSOCIATED TO HEMOPHILIA B 308
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 300
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 300
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 294
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 291
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 284
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 283
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 276
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates 267
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 265
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 260
Hemostasis biomarkers in multiple sclerosis 260
Characterization of a deleted Y chromosome in a male with Turner stigmata 260
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 259
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 258
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 256
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 255
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 254
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 252
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 252
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 251
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 249
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 249
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 248
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 248
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 248
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 247
Attività sulla emostasi di alcune piante della medicina tradizionale indiana 246
Chronic sleep deprivation markedly reduces coagulation factor VII expression 246
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 246
Membrane binding and anticoagulant properties of protein S natural variants 243
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 243
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 243
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 241
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 241
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 241
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 236
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 236
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 235
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 234
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 232
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 231
Evidence for an overlapping role of clock and npas2 transcription factors in liver circadian oscillators 231
c-myc oncogene alterations in human thyroid carcinomas. 227
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 226
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 225
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 225
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 224
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 223
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 223
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 222
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 222
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 222
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 220
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 219
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 219
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 219
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 217
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 215
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 215
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 215
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 215
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 214
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 214
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 213
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 213
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 213
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 212
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 212
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 212
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 211
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 211
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 208
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 207
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 206
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 205
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 205
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 205
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 204
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 203
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 203
Plasma levels of soluble NCAM in multiple sclerosis 203
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 202
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 202
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 202
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 201
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 200
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 200
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 200
Factor VII mutant V154G models a zymogen-like form of factor VIIa 199
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 199
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 198
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 198
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 197
Totale 25.558
Salva come PNG Salva come JPEG
Categoria #
all - tutte 333.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.170
Totale 335.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.189 0 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/20259.468 266 186 817 272 1.175 920 242 468 1.492 1.197 1.356 1.077
2025/202629.867 2.588 1.191 2.610 3.726 4.020 1.831 3.329 1.476 4.398 2.817 1.231 650
2026/20271.392 690 702 0 0 0 0 0 0 0 0 0 0
Totale 74.997